1. Regulatory Mechanisms of the Molecular Pathways in Fibrosis Induced by MicroRNAs
   Cui Yang et al, 2016, Chin Med J CrossRef
2. C-peptide exhibits a late induction effect on matrix metallopeptidase-9 in high glucose-stimulated rat mesangial cells
   Junxia Wang et al, 2016 CrossRef
3. Non-genetic mechanisms of diabetic nephropathy
   Qiuxia Han et al, 2017, Front. Med. CrossRef
4. Nephrin loss is reduced by grape seed proanthocyanidins in the experimental diabetic nephropathy rat model
   Xianhua Li et al, 2017 CrossRef
5. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies
   Alieh Gholaminejad et al, 2018, J Nephrol CrossRef
6. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression
   Alireza Mafi et al, 2018, J Cell Physiol CrossRef
7. Comprehensive analysis of differentially expressed microRNAs and mRNAs in dorsal root ganglia from streptozotocin-induced diabetic rats
   Guojun Guo et al, 2018, PLoS ONE CrossRef
8. Alpinia oxyphylla Miq. extract changes miRNA expression profiles in db-/db- mouse kidney
   Guankui Du et al, 2017, Biol Res CrossRef
9. Pathogenesis and Development of Patellar Tendon Fibrosis in a Rabbit Overuse Model
   Haitao Liu et al, 2020, Am J Sports Med CrossRef
10. MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy
    Hong Zhou et al, 2021, Front. Cell Dev. Biol. CrossRef
11. Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment
    Zoe X. Malchiodi et al, 2021, Cancers CrossRef
12. WGCNA Analysis Identifies Polycystic Ovary Syndrome-Associated Circular RNAs That Interact with RNA-Binding Proteins and Sponge miRNAs
    Mengxiong Li et al, 2021, IJGM CrossRef
13. Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
    Jiahao Chen et al, 2022, Front. Immunol. CrossRef
14. Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non-alcoholic Steatohepatitis.
    Atoosa Rabiee et al, 2022, Clin Pharmacol Ther CrossRef
15. MicroRNAs: Key modulators of inflammation-associated diseases
    Bilash Chatterjee et al, 2023, Seminars in Cell & Developmental Biology CrossRef
16. Long non-coding RNA DLX6-AS1 is the key mediator of glomerular podocyte injury and albuminuria in diabetic nephropathy by targeting the miR-346/GSK-3β signaling pathway
    Jia Guo et al, 2023, Cell Death Dis CrossRef
17. CircGAB1 Facilitates Podocyte Injury Through Sponging miR-346 and Activating MAPK6 in Diabetic Nephropathy
    Pingyue Ma et al, 2023, Appl Biochem Biotechnol CrossRef
18. Alisol A inhibits the circ_0001831/miR‐346/LIN28B pathway to ameliorate high glucose‐induced injury of human renal mesangial cells
    Chunjing Yue et al, 2023, Nephrology CrossRef
19. miR-346 regulates the development of ARDS by regulating the function of pulmonary microvascular endothelial cells
    Jing Jiang et al, 2023, Non-coding RNA Research CrossRef
20. Hsa_circ_0008360 promotes high glucose-induced damage in HK-2 cells via miR-346/WNT2B axis
    L. Zhang et al, 2024, J Endocrinol Invest CrossRef
21. A Systematic Review and Meta-Analysis of microRNA Profiling Studies in Chronic Kidney Diseases
    Gantsetseg Garmaa et al, 2024, ncRNA CrossRef
22. The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial
    Victor Ciofoaia et al, 2024, Pharmaceutics CrossRef
23. miR‐193b‐3p and miR‐346 Exert Antihypertensive Effects in the Rostral Ventrolateral Medulla
    Shuai Zhang et al, 2024, JAHA CrossRef